Neoprobe seeks FDA marketing approval of Lymphoseek for use in ILM oncology procedure

[News]

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced it has submitted a New Drug Application (NDA) for Lymphoseek to the U.S. Food and Drug Administration.

More... (http://www.news-medical.net/news/20110811/Neoprobe-seeks-FDA-marketing-approval-of-Lymphoseek-for-use-in-ILM-oncology-procedure.aspx)